| JXSS2500051 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(3.1) | Import Drug Application | 2025-04-28 | | Msd Ireland;Merck Sharp & Dohme Ltd;MSD R&D (China) Co Ltd | | | view |
| JXSL2500043 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2025-03-25 | | Merck Sharp & Dohme Ltd;MSD R&D (China) Co Ltd | | | view |
| JXSB2500024 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products | Supplementary Application | 2025-03-25 | | Msd Ireland;Merck Sharp & Dohme Ltd | | | view |
| JXSL2500036 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2025-03-11 | | Merck Sharp & Dohme Ltd;MSD R&D (China) Co Ltd | | | view |
| JTS2500009 | 帕博利珠单抗注射液（皮下注射） | pembrolizumab | Injection | Biological Products | Disposable Import Drug Application | 2025-01-25 | | BSP Pharmaceuticals Srl;MSD R&D (China) Co Ltd;Merck Sharp & Dohme BV | | | view |
| JTS2500008 | 帕博利珠单抗注射液（皮下注射） | pembrolizumab | Injection | Biological Products | Disposable Import Drug Application | 2025-01-25 | | BSP Pharmaceuticals Srl;Merck Sharp & Dohme BV;MSD R&D (China) Co Ltd | | | view |
| JXSB2400167 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products | Supplementary Application | 2024-12-14 | | Msd Ireland;Merck Sharp & Dohme Ltd | | | view |
| JXSL2400235 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-12-10 | | Merck Sharp & Dohme Ltd;MSD R&D (China) Co Ltd | | | view |
| JXSL2400221 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-11-14 | | Merck Sharp & Dohme Ltd;MSD R&D (China) Co Ltd | | | view |
| JYSB2400237 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(3.1) | Supplementary Application | 2024-11-01 | | Msd Ireland;Merck Sharp & Dohme Ltd | | | view |
| JXSS2400071 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-09-04 | | Msd Ireland;Merck Sharp & Dohme Ltd;MSD R&D (China) Co Ltd | | | view |
| JXSB2400106 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2024-07-27 | | Msd Ireland;Merck Sharp & Dohme Ltd | | | view |
| JXSB2400095 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products | Supplementary Application | 2024-07-12 | | Msd Ireland;Merck Sharp & Dohme Ltd | | | view |
| JXSB2400083 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2024-07-02 | | Msd Ireland;Merck Sharp & Dohme Ltd | | | view |
| JXSB2400059 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products | Supplementary Application | 2024-05-15 | | Msd Ireland;Merck Sharp & Dohme Ltd | | | view |
| JXSL2400084 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-05-01 | | Merck Sharp & Dohme Ltd;MSD R&D (China) Co Ltd | | | view |
| JXSL2400074 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-04-10 | | Merck Sharp & Dohme Ltd;MSD R&D (China) Co Ltd | | | view |
| JXSS2400034 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(3.1) | Import Drug Application | 2024-04-04 | | Msd Ireland;Merck Sharp & Dohme Ltd;MSD R&D (China) Co Ltd | | | view |
| JYSB2400074 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(3.1) | Supplementary Application | 2024-04-04 | | Msd Ireland;Merck Sharp & Dohme Ltd | | | view |
| JXSS2400033 | 帕博利珠单抗注射液 | pembrolizumab | Injection | Biological Products(3.1) | Import Drug Application | 2024-03-28 | | Msd Ireland;Merck Sharp & Dohme Ltd;MSD R&D (China) Co Ltd | | | view |
